Last one… https://t.co/RJ8Vqt3duw fig 8 is really cool.
RT @TeamRadioPharm: Radiopharm Theranostics’ Trivehexin published in European Journal of Nuclear Medicine: • Addressing αvβ6-integrin allo…
RT @TeamRadioPharm: Radiopharm Theranostics’ Trivehexin published in European Journal of Nuclear Medicine: • Addressing αvβ6-integrin allo…
Strong progress made by @TeamRadioPharm with innovative peptidomimetic design. Also took me back to my time at @Mimotopes synthesising RGD peptide libraries. #innovation #radiopharmaceuticals
RT @radiopharm4cure: High unmet medical needs in Pancreatic cancer and Head & Neck. Innovative Mechanism of Action might help.
High unmet medical needs in Pancreatic cancer and Head & Neck. Innovative Mechanism of Action might help.
Radiopharm Theranostics’ Trivehexin published in European Journal of Nuclear Medicine: • Addressing αvβ6-integrin allow to guide theranostic agents to the tumor cells; • αvβ6-integrin represents an extremely valuable theranostic target. Learn more☟ http
Integrin ligands for imaging: happy to announce our joint publication #PathTwitter #radiopharmacy https://t.co/P411zdFeJV
New article: There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography https://t.co/fAoNLt8Atu #pancreaticcancer #oncology https://t.co/A35EgnM5jy